Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.62M | -22.80M | -23.14M | 1.60M | -17.28M |
| Total Depreciation and Amortization | 17.76M | 67.89M | 23.40M | 23.17M | 23.20M |
| Total Amortization of Deferred Charges | 8.69M | 8.39M | 8.47M | 8.70M | 8.39M |
| Total Other Non-Cash Items | 65.78M | 22.03M | 16.88M | 13.95M | 28.94M |
| Change in Net Operating Assets | -23.05M | -45.28M | -6.94M | -26.00M | -38.34M |
| Cash from Operations | 4.57M | -26.23M | 18.67M | 21.42M | 4.91M |
| Capital Expenditure | -13.09M | 2.57M | -17.29M | -11.67M | -6.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -19.50M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -3.00M | -2.44M | -1.87M | -3.00M |
| Cash from Investing | -13.09M | -19.93M | -19.73M | -13.54M | -9.73M |
| Total Debt Issued | 221.00M | 58.58M | -- | -- | -- |
| Total Debt Repaid | -62.50M | 529.00K | 0.00 | 0.00 | -529.00K |
| Issuance of Common Stock | -- | -- | 2.34M | 61.00K | 1.06M |
| Repurchase of Common Stock | -4.59M | -310.00K | -692.00K | -364.00K | -14.33M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.58M | -4.81M | -5.13M | -5.07M | -5.08M |
| Other Financing Activities | -41.48M | 42.95M | -5.53M | -98.01M | 33.77M |
| Cash from Financing | 107.85M | 96.94M | -9.01M | -103.38M | 14.88M |
| Foreign Exchange rate Adjustments | 23.00K | -136.00K | -31.00K | -24.00K | -38.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.35M | 50.65M | -10.10M | -95.53M | 10.02M |